About Us

TAO Surgical is at the forefront of the integration of Ai, Machine Learning, and Robotics into healthcare.

From the beginning

Where we are now

As founding editor of the journal: Artificial Intelligence Surgery, Dr. Andrew Gumbs has been at the forefront of Ai research in surgery. The number of Ai related publications in surgery has increased exponentially over the past couple of years. He has assembled a world class editorial board to review and evaluate cutting edge research in Ai, Machine Learning, and Robotics.

Our mission is to seek out collaborations that will help us incorporate autonomous actions into surgery and patient care to improve the overall patient experience.

Leaders of industry

It's always a good idea to get additional surgical opinions

We are excited to bring our collective expertise and network outreach to future collaborations that will improve and enhance how we approach surgery in the future.

Clinician Entrepeneurs

Nobody knows more about what products need to be developed to improve patient outcomes than the people who use the products day in and day out. If you have an idea for a product that can improve outcomes we can help you bring it to fruition. We can help you with intellectual property, prototyping, manufacturing and marketing and distribution. We can also assist in raising capital and in enterprise development and management. Developing a medical device is a complicated process and we can help you navigate the maze of regulations, documentation, and processes necessary to bring your ideas to fruition.

Investors

What do investors need to know about the companies and emerging technologies they are considering? How and where do you find high potential early stage opportunities to invest in? We can answer these questions and provide you with the sector specific expertise data and investment opportunities that you're looking for.

Everyday we interface with innovative clinicians and researchers who are working on the next breakthrough innovation. We also work with clients who already have product in market and are looking for expansion capital. If you've already discovered the next med tech breakthrough, use our expertise to augment your due diligence advisory team. An independent set of eyes and ears can sometimes bring further clarity to an investment situation. Think of us as a second surgical opinion. We understand the technology and clinical application and more importantly we understand what it takes to bring it successfully to market. While there are no surefire guarantees and no shortcuts it helps to have as much expert information on hand as possible.